Cell Therapy News Volume 23.09 | Mar 17 2022

    0
    28







    2022-03-21 | CTN 23.09


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.09 – 21 March, 2022
    TOP STORY

    PSMA-Targeting TGFβ-Insensitive Armored CAR T Cells in Metastatic Castration-Resistant Prostate Cancer: A Phase I Trial

    Scientists reported results from an in-human Phase I trial of castration-resistant, prostate cancer-directed CAR T cells armored with a dominant-negative transforming growth factor (TGF)- receptor
    [Nature Medicine]

    Abstract
    Dr. Daniel Dever, describes a CRISPR-Cas9-based protocol for gene editing hematopoietic stem cells in this on-demand webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Characterization and Induction of Tissue-Resident Gamma Delta T Cells to Target Hepatocellular Carcinoma

    Investigators showed that higher intratumoral frequencies of γδ T cells, which have potential for HLA-unrestricted tumor reactivity, associated with enhanced hepatocellular carcinoma patient survival.
    [Nature Communications]

    Full Article

    In Situ Antigen Modification-Based Target-Redirected Universal Chimeric Antigen Receptor T (TRUE CAR-T) Cell Therapy in Solid Tumors

    The authors established a TRUE CAR-T cell therapeutic modality, in which exogenous antigens were loaded onto fusogenic nanoparticles to achieve in situ modification of cell membrane in solid tumors, providing targets for subsequent CAR-T cell therapy.
    [Journal of Hematology & Oncology]

    Full Article

    Autologous, Lentivirus-Modified, T Rapa Cell “Micropharmacies” for Lysosomal Storage Disorders

    Scientists demonstrated that ex vivo lentivirus-modified, rapamycin-conditioned CD4+ T cells could also act as next-generation cellular delivery vehicles—that is, “micropharmacies”—to disseminate corrective enzymes for multiple lysosomal storage disorders.
    [EMBO Molecular Medicine]

    Full ArticleGraphical Abstract

    TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency

    The authors studied transplant outcomes in severe combined immunodeficiency (SCID) infants according to donor type, specifically TCRαβ/CD19-depleted haploidentical family donor transplant, and conditioning, through retrospective cohort analysis of 52 consecutive infants with SCID transplanted.
    [Journal of Clinical Immunology]

    Full Article

    Therapeutic Advantages of Combined Gene/Cell Therapy Strategies in a Murine Model of GM2 Gangliosidosis

    Investigators leveraged on the lentiviral vector (LV)-mediated intracerebral gene therapy platform to deliver Hex genes to the CNS and combined this strategy with bone marrow transplantation to provide a timely, pervasive, and long-lasting source of the Hex enzyme in the CNS and periphery of Sandhoff disease mice.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull ArticleGraphical Abstract

    Two for One: Targeting BCMA and CD19 in B Cell Malignancies with Off-the-Shelf Dual-CAR NK-92 Cells

    Researchers evaluated the functionality of mRNA-engineered dual-CAR natural killer (NK)-92 against tumor B cell lines and primary patient samples.
    [Journal of Translational Medicine]

    Full Article

    Neurofunctional and Neuroimaging Readouts for Designing a Preclinical Stem-Cell Therapy Trial in Experimental Stroke

    With the aim of designing a preclinical study evaluating an intracerebral cell-based therapy for stroke, an observational study was performed in the rat suture model of ischemic stroke.
    [Scientific Reports]

    Full Article

    Dental Pulp Regeneration Induced by Allogenic Mesenchymal Stromal Cells Transplantation in a Mature Tooth: A Case Report

    The authors evaluated the capacity of allogeneic mesenchymal stromal cells to induce dental-pulp and apical bone regeneration in a tooth previously endodontically treated.
    [Journal of Endodontics]

    Abstract
    Learn about hPSC maintenance and banking by watching Dr. Tenneille Ludwig's webinar from the Nature Research Round Table on hPSC Quality
    REVIEWS

    Translating Cell Therapies for Neurodegenerative Diseases: Huntington’s Disease as a Model Disorder

    Investigators set out the challenges associated with the clinical translation of cell therapy, using Huntington’s disease as a specific example, and suggest potential strategies to address these challenges.
    [Brain]

    Abstract

    CAR T Cell Therapy and the Tumor Microenvironment: Current Challenges and Opportunities

    Scientists provide an updated review and future perspectives on features of the tumor microenvironment that represent barriers to CART cell therapy efficacy, including competition for metabolic fuels, physical barriers to infiltration, and immunosuppressive factors.
    [Molecular Therapy Oncolytics]

    AbstractFull ArticleGraphical Abstract

    Rejuvenation of Tissue Stem Cells by Intrinsic and Extrinsic Factors

    The authors discuss recent advances in understanding the mechanisms that regulate stem cell regeneration.
    [Stem Cells Translational Medicine]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans

    Enochian BioSciences issued an exclusive sub-license of one of its proprietary technologies that could improve the effectiveness of a potential cure for HIV with an anti-HIV CAR-T therapy that Caring Cross is studying in a clinical trial.
    [Enochian BioSciences]

    Press Release

    I Peace Triples GMP Cell Manufacturing by Expanding CDMO Facility

    I Peace, Inc. announced that the company had tripled its capacity to manufacture GMP grade iPSCs and iPSC-derived differentiated cells by expanding its facility.
    [I Peace, Inc.]

    Press Release
    FEATURED EVENT

    AACR: Advances in the Pathogenesis and Molecular Therapies of Liver Cancer

    May 5 – 8, 2022
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – CAR-T Cell Exhaustion in Solid Tumors

    Seattle, Washington, United States – Fred Hutchinson Cancer Research Center

    Research Engineer – Bioprinted Tissue Therapeutics

    Aspect Biosystems – Vancouver, British Columbia, Canada

    Senior Scientific Officer – Functional Genomics

    Institute of Cancer Research – London, England, United Kingdom

    Research Scientist – CAR T Cells

    BioNTech – Gaithersburg, Maryland, United States

    Research Technician – Placental Development

    Friedrich Miescher Institute for Biomedical Research – Basel, Switzerland

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter